Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Does adding Cinnamon to your coffee help you burn fat?
Cinnamon has been long used around the world in both sweet and savoury dishes and drinks. But a new TikTok ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:16 — 12.7MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Lonely Planet’s Best In Travel Destinations for 2025 Revealed! Who made the list?
Global travel authority Lonely Planet has today unveiled its top destinations to visit next year with the release of Lonely ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 12:42 — 17.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Lauren Rosewarne: Want fries with those lies? (USA Today)
Want fries with those lies - that’s how USA today headlined Donald Trump’s short shift at a McDonalds store in ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 12:30 — 17.2MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS